Dasiglucagon, a recently approved glucagon analog, was faster than fast-acting carbohydrates for resolving hypoglycemia in people with type 1 diabetes, with high patient satisfaction.
Results from 63 people with diabetes and albuminuria in the ROTATE study belie the idea that renin-angiotensin system inhibitors always work best. For many patients, other drug classes work better.
A consensus statement from the ADA and KDIGO recommends more aggressive combined use of several newer, and costly, drug classes to slow progression of diabetic kidney disease.
Zealand Pharma Announces Multiple Presentations at the 82nd Annual American Diabetes Association Scientific Sessions, Including Initial Clinical Data on GLP-1/GLP-2 Dual Agonist Dapiglutide streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.